RankAlpha logo
Back to Rankings

BOLT

Bolt BiotherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
BOLT vs peer average
58/100
BOLT vs. peer average (D vs. D)
Grade spread
C 1 · D 2 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

MTVA is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $8.68M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerMTVAMetaVia
BOLT
Bolt Biotherapeutics
MTVA
MetaVia
Grade
D
D
Momentum
41
69
Value
41
58
Sentiment
-
17
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs MTVA

BOLT / MTVA
Grade Position
In line
BOLT vs. peer average (D vs. D)
58/100
Momentum
41
MTVA
Value
41
MTVA
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs BOLT
1
MTVA
MetaVia Inc Common
D
40/100
Even
2
ASBP
Aspire Biopharma Holdings Inc Common
F
20/100
+1
3
CRIS
Curis Inc Common
D
40/100
Even
4
RNAZ
TransCode Therapeutics Inc Common
F
20/100
+1
5
APRE
Aprea Therapeutics Inc Common
F
20/100
+1
MTVA is the first peer returned for this comparison set.